GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Indegene Ltd (NSE:INDGN) » Definitions » Cash Flow from Others

Indegene (NSE:INDGN) Cash Flow from Others : ₹0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Indegene Cash Flow from Others?

Indegene's cash flow from others for the three months ended in Mar. 2025 was ₹0 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0 Mil.


Indegene Cash Flow from Others Historical Data

The historical data trend for Indegene's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indegene Cash Flow from Others Chart

Indegene Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Cash Flow from Others
-674.14 -242.69 -924.00 -1,441.00 -2,191.00

Indegene Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Indegene Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Indegene Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Indegene's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Indegene Business Description

Traded in Other Exchanges
Address
Outer Ring Road, Aspen Block G4, 3rd Floor, Manyata Embassy Business Park, Nagawara, Bengaluru, KA, IND, 560045
Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations of life sciences companies. The company segment includes Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment.

Indegene Headlines

No Headlines